maxidrate
libbs farmacÊutica ltda - cloreto de sÓdio - descongestionantes nasais topicos
mabthera
produtos roche quÍmicos e farmacÊuticos s.a. - rituximabe - antineoplasico
lumeblue (previously known as methylthioninium chloride cosmo)
alfasigma s.p.a. - cloreto de metiltionínio - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.
pedmarqsi
fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - todos os outros produtos terapêuticos - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.
clopidogrel tad
tad pharma gmbh - clopidogrel (as hydrochloride) - peripheral vascular diseases; stroke; myocardial infarction - agentes antitrombóticos - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.
eucreas
novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
daxocox
ecuphar nv - enflicoxib - produtos antiinflamatórios e anti-reumáticos - cães - for the treatment of pain and inflammation associated with osteoarthritis (or degenerative joint disease) in dogs.
sapropterin dipharma
dipharma arzneimittel gmbh - sapropterin dihydrochloride - fenilcetonurias - outro aparelho digestivo e metabolismo produtos, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.
citrato de gálio (67ga) solução injectável curium netherlands 37 mbq/ml solução injetável
curium netherlands b.v. - citrato de gálio (67ga) - solução injetável - 37 mbq/ml - citrato de gálio (67ga) 37 mbq/ml - gallium (67ga) citrate - radiofármaco - duração do tratamento: curta ou média duração
citrato de gálio (67ga) solução injectável curium netherlands 37 mbq/ml solução injetável
curium netherlands b.v. - citrato de gálio (67ga) - solução injetável - 37 mbq/ml - citrato de gálio (67ga) 37 mbq/ml - gallium (67ga) citrate - radiofármaco - duração do tratamento: curta ou média duração